WA
MDCO

Whitebox Advisors’s Medicines Co MDCO Stock Holding History

Whitebox Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-39,036
Closed -$1.2M – 427
2013
Q2 		$1.2M Buy
+39,036
New +$1.31M 0.06% 164

Other funds holding MDCO

SAC
Smith Affiliated Capital New York $86.5B AUM 5.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Whitebox Advisors's MDCO Position: Q3 2013 in Review

Whitebox Advisors sold out of Medicines Co (MDCO) in Q3 2013, closing a stake of 39,036 shares — an estimated $1.2M sold.

Whitebox Advisors first reported a position in MDCO in Q2 2013 and held it in 1 quarter. The position peaked at $1.2M in Q2 2013. 172 funds tracked by Wall St. Rank hold MDCO as of Q3 2013.

  • Whitebox Advisors reported no remaining Medicines Co position as of Q3 2013 after selling out during the quarter.
  • Whitebox Advisors sold 39,036 Medicines Co shares in Q3 2013, an estimated $1.2M.
  • Whitebox Advisors first reported a position in Medicines Co in Q2 2013 and held it in 1 quarter.
  • Whitebox Advisors's Medicines Co position peaked at $1.2M in Q2 2013.
  • 172 funds tracked by Wall St. Rank held Medicines Co as of Q3 2013.

Based on Whitebox Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.